ATE346080T1 - Steroid-verbindungen mit anti-tumoraler wirkung - Google Patents

Steroid-verbindungen mit anti-tumoraler wirkung

Info

Publication number
ATE346080T1
ATE346080T1 AT03789347T AT03789347T ATE346080T1 AT E346080 T1 ATE346080 T1 AT E346080T1 AT 03789347 T AT03789347 T AT 03789347T AT 03789347 T AT03789347 T AT 03789347T AT E346080 T1 ATE346080 T1 AT E346080T1
Authority
AT
Austria
Prior art keywords
steroid compounds
present
steroid
relates
tumoral effect
Prior art date
Application number
AT03789347T
Other languages
English (en)
Inventor
Jean-Claude Braekman
Quaquebeke Eric Van
Laurent Ingrassia
Janique Dewelle
Robert Kiss
Francis Darro
Original Assignee
Unibioscreen Sa
Univ Bruxelles
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unibioscreen Sa, Univ Bruxelles filed Critical Unibioscreen Sa
Application granted granted Critical
Publication of ATE346080T1 publication Critical patent/ATE346080T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
AT03789347T 2002-12-18 2003-12-18 Steroid-verbindungen mit anti-tumoraler wirkung ATE346080T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02447257 2002-12-18
US43583402P 2002-12-20 2002-12-20

Publications (1)

Publication Number Publication Date
ATE346080T1 true ATE346080T1 (de) 2006-12-15

Family

ID=32598801

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03789347T ATE346080T1 (de) 2002-12-18 2003-12-18 Steroid-verbindungen mit anti-tumoraler wirkung

Country Status (14)

Country Link
US (1) US20060149045A1 (de)
EP (1) EP1572715B1 (de)
JP (1) JP2006511544A (de)
CN (1) CN100402546C (de)
AT (1) ATE346080T1 (de)
AU (1) AU2003293943B2 (de)
CA (1) CA2509283A1 (de)
DE (1) DE60309926T2 (de)
DK (1) DK1572715T3 (de)
ES (1) ES2277138T3 (de)
MX (1) MXPA05006378A (de)
PT (1) PT1572715E (de)
WO (1) WO2004055039A1 (de)
ZA (1) ZA200504777B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101352635B1 (ko) * 2011-12-29 2014-01-20 연세대학교 산학협력단 신규 혈관누출 차단제
EP3162875B1 (de) * 2015-10-30 2018-05-23 Merck Patent GmbH Polymerisierbare verbindungen und verwendung davon in flüssigkristallanzeigevorrichtungen
US10434106B2 (en) * 2017-05-19 2019-10-08 Warsaw Orthopedic, Inc. Oxysterol-statin compounds for bone growth
CN122374322A (zh) * 2024-07-05 2026-07-10 库拉科有限公司 内皮功能障碍治疗剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3584050B2 (ja) * 1993-05-14 2004-11-04 株式会社医薬分子設計研究所 ステロイド化合物

Also Published As

Publication number Publication date
PT1572715E (pt) 2007-01-31
HK1085744A1 (en) 2006-09-01
DK1572715T3 (da) 2007-04-02
DE60309926D1 (de) 2007-01-04
DE60309926T2 (de) 2007-09-13
US20060149045A1 (en) 2006-07-06
MXPA05006378A (es) 2006-02-08
JP2006511544A (ja) 2006-04-06
WO2004055039A1 (en) 2004-07-01
EP1572715A1 (de) 2005-09-14
ZA200504777B (en) 2006-04-26
CN100402546C (zh) 2008-07-16
EP1572715B1 (de) 2006-11-22
CN1745090A (zh) 2006-03-08
ES2277138T3 (es) 2007-07-01
AU2003293943B2 (en) 2009-08-13
CA2509283A1 (en) 2004-07-01
AU2003293943A1 (en) 2004-07-09

Similar Documents

Publication Publication Date Title
BR0309343A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
CY1109242T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
BR0309342A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
GB0112348D0 (en) Compounds
MY148690A (en) Novel macrocyclic inhibitors of hepatitis c virus replication
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
WO2005030766A8 (en) Phenyl - carboxamide compounds useful for treating pain
BR0315580A (pt) Derivados de metileno uréia
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
PL1613315T3 (pl) Pochodne chinolino-2-onu do leczenia chorób dróg oddechowych
MXPA05000765A (es) Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos.
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
ATE238981T1 (de) Antitumorwirkstoffe
BR0311491A (pt) Composto, composição farmacêutica, uso de um composto, e, método terapêutico para tratar câncer em um mamìfero
MXPA05010020A (es) Derivados de oxamida.
TW200639159A (en) Treatment of pain
MX2007004955A (es) Metodo de tratar cancer con formulaciones de compeusto de platino a base de lipido administradas intraperitonealmente.
BR0309996A (pt) Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias
DE60309926D1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
ATE393624T1 (de) Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs
GB0012795D0 (en) Organic compounds
WO2005035500A3 (en) Therapeutic agents useful for treating pain

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1572715

Country of ref document: EP

REN Ceased due to non-payment of the annual fee